Hartman Institute for Therapeutic Organ Regeneration

Adult cardiac stem cells--where do we go from here?

TitleAdult cardiac stem cells--where do we go from here?
Publication TypeJournal Article
Year of Publication2003
AuthorsEdelberg JM, Xaymardan M, Rafii S, Hong MK
JournalSci Aging Knowledge Environ
Volume2003
Issue26
PaginationPE17
Date Published2003 Jul 02
ISSN1539-6150
KeywordsAnimals, Bone Marrow Cells, Cardiovascular Agents, Cardiovascular Diseases, Cell Differentiation, Clinical Trials as Topic, Humans, Myocardium, Myocytes, Cardiac, Stem Cell Transplantation, Stem Cells
Abstract

A potential treatment for cardiovascular disease involves the transplantation of a patient's bone marrow stem cells into the heart of that same patient. In order to maximize the potential benefits to select patient populations, the continued clinical development of this technology will require a comprehensive understanding of the role(s) of the transplanted cells in the repair of damaged heart tissue as well as an understanding of which types of cardiac injury can be repaired by this approach. The widespread application of cardiovascular stem cell therapies, however, will likely be based on pharmacological approaches to enhance the capacity of endogenous bone marrow stem cells to provide for the replacement of cardiac muscle and vascular cells after myocardial injury.

DOI10.1126/sageke.2003.26.pe17
Alternate JournalSci Aging Knowledge Environ
PubMed ID12844537

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065